Fennec Pharmaceuticals Inc. (FENC) Earnings History
Annual and quarterly earnings data from 2000 to 2024
Loading earnings history...
FENC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
FENC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 93.3% | 5.4% | -0.9% |
| 2023 | 94.1% | -60.1% | -75.5% |
| 2022 | 94.4% | -1471.6% | -1544.9% |
| 2021 | - | - | - |
| 2020 | 100.0% | -10520.6% | -10652.4% |
Download Data
Export FENC earnings history in CSV or JSON format
Free sign-in required to download data
Fennec Pharmaceuticals Inc. (FENC) Earnings Overview
As of May 8, 2026, Fennec Pharmaceuticals Inc. (FENC) reported trailing twelve-month net income of -$7M, reflecting +97.3% year-over-year growth. The company earned $-0.25 per diluted share over the past four quarters, with a net profit margin of -0.9%.
Looking at the long-term picture, FENC's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2011.
Fennec Pharmaceuticals Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including LCTX (-$64M net income, -436.5% margin), SNOA (-$3M net income, -24.2% margin), HALO ($317M net income, 22.7% margin), FENC has outperformed on profitability metrics. Compare FENC vs LCTX →
FENC Earnings vs Peers
Earnings metrics vs comparable public companies
FENC Historical Earnings Data (2000–2024)
25 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $-436,000 | +97.3% | $3M | $-0.02 | -0.9% | 5.4% |
| 2023 | -$16M | +29.5% | -$13M | $-0.60 | -75.5% | -60.1% |
| 2022 | -$23M | -32.5% | -$22M | $-0.95 | -1544.9% | -1471.6% |
| 2021 | -$17M | +5.1% | -$17M | $-0.67 | - | - |
| 2020 | -$18M | -38.5% | -$18M | $-0.76 | -10652.4% | -10520.6% |
| 2019 | -$13M | -32.2% | -$13M | $-0.63 | - | - |
| 2018 | -$10M | -40.3% | -$10M | $-0.52 | - | - |
| 2017 | -$7M | -152.6% | -$7M | $-0.47 | - | - |
| 2016 | -$3M | -323.2% | -$3M | $-0.22 | - | - |
| 2015 | $-659,000 | +69.7% | -$2M | $-0.06 | - | - |
See FENC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FENC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FENC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFENC — Frequently Asked Questions
Quick answers to the most common questions about buying FENC stock.
Is FENC growing earnings?
FENC EPS is $-0.25, with earnings growth accelerating to +97.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-7M.
What are FENC's profit margins?
Fennec Pharmaceuticals Inc. net margin is -0.9%, with operating margin at +5.4%. Below-average margins reflect competitive or cost pressures.
How consistent are FENC's earnings?
FENC earnings data spans 2000-2024. The accelerating earnings trend is +97.3% YoY. Historical data enables comparison across business cycles.